Michael Mason

2019

In 2019, Michael Mason earned a total compensation of $956.7K as Senior Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$75,000
Option Awards$529,935
Salary$340,332
Other$11,430
Total$956,697

Mason received $529.9K in option awards, accounting for 55% of the total pay in 2019.

Mason also received $75K in non-equity incentive plan, $340.3K in salary and $11.4K in other compensation.

Rankings

In 2019, Michael Mason's compensation ranked 9,463rd out of 13,971 executives tracked by ExecPay. In other words, Mason earned more than 32.3% of executives.

ClassificationRankingPercentile
All
9,463
out of 13,971
32nd
Division
Manufacturing
3,803
out of 5,698
33rd
Major group
Chemicals And Allied Products
1,440
out of 2,197
35th
Industry group
Drugs
1,229
out of 1,883
35th
Industry
Pharmaceutical Preparations
914
out of 1,395
35th
Source: SEC filing on April 7, 2021.

Mason's colleagues

We found three more compensation records of executives who worked with Michael Mason at Karyopharm Therapeutics in 2019.

2019

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2019

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2019

Christopher Primiano

Karyopharm Therapeutics

General Counsel

News

In-depth

You may also like